Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Pichia pastoris Mut(S) strains are prone to misincorporation of O-methyl-L-homoserine at methionine residues when methanol is used as the sole carbon source.

Schotte P, Dewerte I, De Groeve M, De Keyser S, De Brabandere V, Stanssens P.

Microb Cell Fact. 2016 Jun 7;15:98. doi: 10.1186/s12934-016-0499-2.

2.

Antithrombotic drug candidate ALX-0081 shows superior preclinical efficacy and safety compared with currently marketed antiplatelet drugs.

Ulrichts H, Silence K, Schoolmeester A, de Jaegere P, Rossenu S, Roodt J, Priem S, Lauwereys M, Casteels P, Van Bockstaele F, Verschueren K, Stanssens P, Baumeister J, Holz JB.

Blood. 2011 Jul 21;118(3):757-65. doi: 10.1182/blood-2010-11-317859. Epub 2011 May 16.

PMID:
21576702
3.

AFLP-based transcript profiling.

Vos P, Stanssens P.

Curr Protoc Mol Biol. 2002 Feb;Chapter 25:Unit 25B.5. doi: 10.1002/0471142727.mb25b05s57.

PMID:
18265312
5.

Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry.

Ehrich M, Nelson MR, Stanssens P, Zabeau M, Liloglou T, Xinarianos G, Cantor CR, Field JK, van den Boom D.

Proc Natl Acad Sci U S A. 2005 Nov 1;102(44):15785-90. Epub 2005 Oct 21.

6.

High-throughput MALDI-TOF discovery of genomic sequence polymorphisms.

Stanssens P, Zabeau M, Meersseman G, Remes G, Gansemans Y, Storm N, Hartmer R, Honisch C, Rodi CP, Böcker S, van den Boom D.

Genome Res. 2004 Jan;14(1):126-33.

7.

A strategy for the rapid discovery of disease markers using the MassARRAY system.

Rodi CP, Darnhofer-Patel B, Stanssens P, Zabeau M, van den Boom D.

Biotechniques. 2002 Jun;Suppl:62-6, 68-9. No abstract available.

PMID:
12083400
8.

Vaccination with neutrophil inhibitory factor reduces the fecundity of the hookworm Ancylostoma ceylanicum.

Ali F, Brown A, Stanssens P, Timothy LM, Soule HR, Pritchard DI.

Parasite Immunol. 2001 May;23(5):237-49.

9.

The integrin alpha 2 beta 1 (GPIa/IIa)-I-domain inhibits platelet-collagen interaction.

Depraetere H, Wille C, Gansemans Y, Stanssens P, Lauwereys M, Baruch D, De Reys S, Deckmyn H.

Thromb Haemost. 1997 May;77(5):981-5.

PMID:
9184414
10.
11.

Surface expression and ligand-based selection of cDNAs fused to filamentous phage gene VI.

Jespers LS, Messens JH, De Keyser A, Eeckhout D, Van den Brande I, Gansemans YG, Lauwereys MJ, Vlasuk GP, Stanssens PE.

Biotechnology (N Y). 1995 Apr;13(4):378-82.

PMID:
9634780
12.

An echistatin-like Arg-Gly-Asp (RGD)-containing sequence in the heavy chain CDR3 of a murine monoclonal antibody that inhibits human platelet glycoprotein IIb/IIIa function.

Deckmyn H, Stanssens P, Hoet B, Declerck PJ, Lauwereys M, Gansemans Y, Tornai I, Vermylen J.

Br J Haematol. 1994 Jul;87(3):562-71.

PMID:
7993797
13.

A hookworm glycoprotein that inhibits neutrophil function is a ligand of the integrin CD11b/CD18.

Moyle M, Foster DL, McGrath DE, Brown SM, Laroche Y, De Meutter J, Stanssens P, Bogowitz CA, Fried VA, Ely JA, et al.

J Biol Chem. 1994 Apr 1;269(13):10008-15.

14.

Engineering cysteine mutants to obtain crystallographic phases with a cutinase from Fusarium solani pisi.

Martinez C, de Geus P, Stanssens P, Lauwereys M, Cambillau C.

Protein Eng. 1993 Feb;6(2):157-65.

PMID:
8475042
15.

Protein engineering of xylose (glucose) isomerase from Actinoplanes missouriensis. 2. Site-directed mutagenesis of the xylose binding site.

Lambeir AM, Lauwereys M, Stanssens P, Mrabet NT, Snauwaert J, van Tilbeurgh H, Matthyssens G, Lasters I, De Maeyer M, Wodak SJ, et al.

Biochemistry. 1992 Jun 23;31(24):5459-66.

PMID:
1610792
16.

Arginine residues as stabilizing elements in proteins.

Mrabet NT, Van den Broeck A, Van den brande I, Stanssens P, Laroche Y, Lambeir AM, Matthijssens G, Jenkins J, Chiadmi M, van Tilbeurgh H, et al.

Biochemistry. 1992 Mar 3;31(8):2239-53.

PMID:
1540579
18.

Contribution of hydrogen bonding to the conformational stability of ribonuclease T1.

Shirley BA, Stanssens P, Hahn U, Pace CN.

Biochemistry. 1992 Jan 28;31(3):725-32.

PMID:
1731929
20.
21.

Enhancing the thermostability of glucose isomerase by protein engineering.

Quax WJ, Mrabet NT, Luiten RG, Schuurhuizen PW, Stanssens P, Lasters I.

Biotechnology (N Y). 1991 Aug;9(8):738-42.

PMID:
1367634
22.

Quantitative analysis of the contribution of Glu46 and Asn98 to the guanosine specificity of ribonuclease T1.

Steyaert J, Opsomer C, Wyns L, Stanssens P.

Biochemistry. 1991 Jan 15;30(2):494-9.

PMID:
1899029
23.

Histidine-40 of ribonuclease T1 acts as base catalyst when the true catalytic base, glutamic acid-58, is replaced by alanine.

Steyaert J, Hallenga K, Wyns L, Stanssens P.

Biochemistry. 1990 Sep 25;29(38):9064-72.

PMID:
1980211
24.

Conformational stability and activity of ribonuclease T1 and mutants. Gln25----Lys, Glu58----Ala, and the double mutant.

Shirley BA, Stanssens P, Steyaert J, Pace CN.

J Biol Chem. 1989 Jul 15;264(20):11621-5.

25.

Efficient oligonucleotide-directed construction of mutations in expression vectors by the gapped duplex DNA method using alternating selectable markers.

Stanssens P, Opsomer C, McKeown YM, Kramer W, Zabeau M, Fritz HJ.

Nucleic Acids Res. 1989 Jun 26;17(12):4441-54.

26.

Characterization of a gram-positive broad-host-range plasmid isolated from Lactobacillus hilgardii.

Josson K, Scheirlinck T, Michiels F, Platteeuw C, Stanssens P, Joos H, Dhaese P, Zabeau M, Mahillon J.

Plasmid. 1989 Jan;21(1):9-20.

PMID:
2727147
27.

Expression of the chemically synthesized gene for ribonuclease T1 in Escherichia coli using a secretion cloning vector.

Quaas R, McKeown Y, Stanssens P, Frank R, Blöcker H, Hahn U.

Eur J Biochem. 1988 May 2;173(3):617-22.

28.

Inefficient translation initiation causes premature transcription termination in the lacZ gene.

Stanssens P, Remaut E, Fiers W.

Cell. 1986 Mar 14;44(5):711-8.

PMID:
3081264
29.

Use of the phage lambda PL promoter for high-level expression of human interferons in Escherichia coli.

Remaut E, Stanssens P, Simons G, Fiers W.

Methods Enzymol. 1986;119:366-75. No abstract available.

PMID:
2429151
30.
31.

Inducible high level synthesis of mature human fibroblast interferon in Escherichia coli.

Remaut E, Stanssens P, Fiers W.

Nucleic Acids Res. 1983 Jul 25;11(14):4677-88.

32.

The human fibroblast and human immune interferon genes and their expression in homologous and heterologous cells.

Fiers W, Remaut E, Devos R, Cheroutre H, Contreras R, Gheysen D, Degrave W, Stanssens P, Tavernier J, Taya Y, Content J.

Philos Trans R Soc Lond B Biol Sci. 1982 Sep 24;299(1094):29-38.

PMID:
6183692
33.

Functional expression of individual plasmid-coded RNA bacteriophage MS2 genes.

Remaut E, Waele PD, Marmenout A, Stanssens P, Fiers W.

EMBO J. 1982;1(2):205-9.

34.

The human fibroblast interferon gene(s) and their expression in heterologous cells.

Fiers W, Degrave W, Derynck R, Devos R, Gheysen D, Remaut E, Stanssens P, Tavernier J, Content J, De Clercq E.

Princess Takamatsu Symp. 1982;12:227-36.

PMID:
6762376
35.

Isolation and characterization of a human fibroblast interferon gene and its expression in Escherichia coli.

Derynck R, Devos R, Remaut E, Saman E, Stanssens P, Tavernier J, Volckaert G, Content J, De Clercq E, Fiers W.

Rev Infect Dis. 1981 Nov-Dec;3(6):1186-95. Review.

PMID:
6177026
36.

Plasmid vectors for high-efficiency expression controlled by the PL promoter of coliphage lambda.

Remaut E, Stanssens P, Fiers W.

Gene. 1981 Oct;15(1):81-93. No abstract available.

PMID:
6271633
37.

Expression of human fibroblast interferon gene in Escherichia coli.

Derynck R, Remaut E, Saman E, Stanssens P, De Clercq E, Content J, Fiers W.

Nature. 1980 Sep 18;287(5779):193-7.

PMID:
6159534

Supplemental Content

Loading ...
Support Center